GeneDx Appoints Everett Cunningham as New CEO
GeneDx (WGS) has announced the appointment of Everett Cunningham as its new Chief Executive Officer and a member of its board of directors. The transition is scheduled to take effect on or before December 15, 2026. Cunningham will succeed Katherine Stueland, who is stepping down from her role at the company. This leadership change marks a planned succession for the genomic testing provider.
Coverage
- Quanterix appoints Jim Gute as interim CEO as Everett Cunningham steps down
- GeneDx Appoints Everett Cunningham as New CEO
- Home Depot expects FY2026 sales growth of ~4.5% as leadership succession takes next step
- Home Depot Taps CFO Richard McPhail to Lead, Narrows Profit Outlook
- Home Depot Appoints CFO Richard McPhail as New CEO